Modipafant

N/A

Report date: 2022/08/30 20:00:42
NME

Base Information

Drug NameModipafant
Drug Alias Name莫地帕泛modipafantum60-P-002UK-80067
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet activating factor receptor antagonists
TargetsPlatelet activating factor receptor
Therapy Area/IndicationsDengue
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator Companies60 Degrees Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies60 Degrees Pharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsDengue

Other Information

ATC CodeN/A
Related LinksN/A